Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Vitam Horm ; 113: 239-258, 2020.
Article in English | MEDLINE | ID: mdl-32138950

ABSTRACT

In mammals, three subtypes of V-receptors have been identified in the kidney. The effects of vasopressin, a hormone synthesized in the hypothalamus, are triggered by three distinct receptor isoforms: V2, V1a, and V1b. Stimulation of V2-receptors regulates urine osmotic concentration by increasing sodium reabsorption in the thick ascending limb of the loop of Henle and enhancing osmotic permeability of the epithelium cells in the collecting duct. Stimulation of V1a-receptors inhibits renal sodium reabsorption and induces natriuresis, comparable to the effect of the diuretic furosemide, in the thick ascending limb of the loop of Henle. Stimulation of V1b-receptors induces potassium secretion in the final parts of the distal segments and initial parts of the collecting ducts. In this review, we discuss the role of vasopressin and its interaction with V-receptor subtypes in natriuresis and for stabilizing the physicochemical parameters of the internal environment and water-salt homeostasis in humans. A better understanding of these systems and their regulation is necessary to facilitate identification of additional system components and mechanisms, clarify their contribution during various normal and pathological functional states, and suggest novel strategies for the development of therapeutic interventions.


Subject(s)
Kidney/metabolism , Receptors, Vasopressin/metabolism , Sodium/metabolism , Humans , Kidney/physiology , Renal Elimination/physiology , Renal Reabsorption/physiology
2.
Bull Exp Biol Med ; 166(4): 417-420, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30788735

ABSTRACT

We developed an approach for quantitative assay of injected vasopressin in urine samples by ELISA under conditions of physiological suppression of hormone secretion from the neurohypophysis into the blood. In experiments on unanesthetized rats, water load (5 ml/100 g body weight) almost completely blocked secretion of arginine-vasopressin. Injection of arginine-vasopressin in a dose of 0.1 nmol/100 g body weight after water load enhanced reabsorption of solute-free water and renal excretion of Na+, K+, and Mg2+ by 13.3, 5.5, and 5.0 times, respectively; urinary excretion of Ca2+ remained unchanged. It was found that urinary excretion of arginine-vasopressin directly correlated with reabsorption of solute-free water and renal sodium excretion.


Subject(s)
Arginine Vasopressin/urine , Renal Reabsorption/physiology , Sodium/metabolism , Water/metabolism , Animals , Calcium/metabolism , Enzyme-Linked Immunosorbent Assay , Magnesium/metabolism , Osmoregulation/physiology , Potassium/metabolism , Rats , Rats, Wistar
3.
Dokl Biol Sci ; 479(1): 60-63, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29790029

ABSTRACT

After a water load in rats hyperhydration occurs and the secretion of oxytocin increases by the neurohypophysis. This increases the water diuresis, the water is quickly excreted by the kidney, and the recovery of osmotic homeostasis is accelerated.


Subject(s)
Oxytocin/blood , Water-Electrolyte Balance , Animals , Female , Rats , Rats, Wistar
4.
Bull Exp Biol Med ; 163(6): 701-704, 2017 Oct.
Article in English | MEDLINE | ID: mdl-29063315

ABSTRACT

V1a receptor agonist [Phe2, Ile3, Orn8]-vasopressin produces maximum diuretic and saluretic effects in a dose of 0.1 nmol/100 g body weight: renal excretion of Na+ increases by 50 times in comparison with the initial level over 90 min, excretion of K+, Mg2+, and Са2+ increases by 3, 2, and 16 times, respectively. New formulas were proposed for calculation of the clearance considering total cation content in the extracellular fluid and the time of total effect of the injected dose. After injection of V1a receptors agonist, clearance of Na+ was 7% of its total content in the extracellular fluid, the corresponding values for K+, Mg2+, and Ca2+ were 63, 35, and 6%, respectively. The proposed approach differs significantly from the standard cation excretion evaluation and characterizes selective shifts in ion balance induced by physiologically active substances and possible side effects due to unbalanced loss of certain ions.


Subject(s)
Diuretics/pharmacology , Ornipressin/analogs & derivatives , Receptors, Vasopressin/agonists , Renal Elimination/drug effects , Animals , Calcium/urine , Cations, Divalent , Cations, Monovalent , Drug Administration Schedule , Extracellular Fluid/chemistry , Furosemide/pharmacology , Injections, Intramuscular , Magnesium/urine , Ornipressin/pharmacology , Potassium/urine , Rats , Rats, Wistar , Receptors, Vasopressin/metabolism , Renal Elimination/physiology , Sodium/urine
5.
Bull Exp Biol Med ; 160(6): 751-4, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27165083

ABSTRACT

The role of subtypes of vasopressin receptors in modulation of renal sodium reabsorption was studied in in vivo experiments on Wistar rats. Selective V1a receptor agonist reduced sodium reabsorption in the kidneys and expression of these receptors increased by practically 100 times. This effect was similar to the effect of furosemide. Selective V2 receptor agonist enhanced sodium reabsorption in the kidney and simultaneously increased reabsorption of solute-free water. Stimulation of V1b receptors did not affect sodium transport. Our findings attest to the key role of V1a receptors in the regulation of renal excretion of sodium ions.


Subject(s)
Deamino Arginine Vasopressin/pharmacology , Diuretics/pharmacology , Furosemide/pharmacology , Receptors, Vasopressin/agonists , Sodium/metabolism , Animals , Biological Transport , Drug Evaluation, Preclinical , Female , Kidney/drug effects , Kidney/metabolism , Rats, Wistar
6.
J Neuroendocrinol ; 28(4)2016 04.
Article in English | MEDLINE | ID: mdl-26791475

ABSTRACT

The present study aimed to investigate the potential physiological role of vasopressin and the incretin hormone of the gastrointestinal tract (glucagon-like peptide-1; GLP-1) in the regulation of the water-salt balance in a hyperosmolar state as a result of sodium loadings. In rats, the administration of hypertonic NaCl solution resulted in a significant increase in natriuresis, which correlated with the vasopressin excretion rate. Natriuresis following an i.p. NaCl load (23.2 ± 1.4 µmol/min/kg) was enhanced by inhibition of V2 receptors (51.6 ± 3.7 µmol/min/kg, P < 0.05) and was reduced by a V1a antagonist injection (6.3 ± 1.1 µmol/min/kg, P < 0.05). Compared to i.p. salt administration, oral NaCl loading induced a significant increase in the plasma GLP-1 level within 5 min and resulted in more prominent natriuresis and a smaller increase in blood sodium concentration. It was hypothesised that the basis for the fast elimination of excess sodium following an oral NaCl load could be the involvement of GLP-1 in osmoregulation combined with vasopressin. It was demonstrated that GLP-1 mimetic exenatide (1.5 nmol/kg) produced a significant decrease in proximal reabsorption and an increase in fractional sodium excretion (from 0.15 ± 0.04% to 9 ± 1%). It was also shown that vasopressin at doses of 1-10 µg/kg and the selective V1a agonist (1 µg/kg) induced an increase in sodium fractional excretion to 10 ± 2% and 8 ± 2%, respectively. Combined administration of exenatide and V1a agonist revealed their cumulative natriuretic effect, and sodium fractional excretion increased by up to 18 ± 2%. These data suggest that GLP-1 combined with vasopressin could be involved in the regulation of sodium balance in the hyperosmolar state as a result of NaCl loading. Vasopressin regulates the reabsorption of a significant portion of filtered sodium in the distal segment of the nephron and modulates the natriuretic effect of GLP-1.


Subject(s)
Glucagon-Like Peptide 1/physiology , Kidney/metabolism , Natriuresis/physiology , Sodium/metabolism , Vasopressins/physiology , Animals , Antidiuretic Hormone Receptor Antagonists/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Exenatide , Female , Glucagon-Like Peptide 1/blood , Kidney/drug effects , Natriuresis/drug effects , Osmolar Concentration , Peptides/pharmacology , Rats , Receptors, Vasopressin/agonists , Saline Solution, Hypertonic/pharmacology , Sodium/blood , Venoms/pharmacology
7.
Ross Fiziol Zh Im I M Sechenova ; 102(10): 1185-94, 2016 Oct.
Article in Russian | MEDLINE | ID: mdl-30193436

ABSTRACT

In experiments with female Wistar rats it was shown that analogs of neurohypophysial hormones administered to gastrointestinal tract preserved their specific physiological activity - they increased solute-free water reabsorption and urinary sodium and potassium excretion. Doses of deamino-vasotocin exerted antidiuretic and natriuretic effects following its oral administration were 50 and 200 times higher compared to maximal effective ones after intramuscular injection. Inhibition of gastrointestinal proteases by aprotinine enhanced effects of nonapeptides; the amount of peptide absorbed from the intestine under these conditions was approximately 0.5 % of orally introduced substance. In contrast to analogs of neurohypophysial nonapeptides, glucagon-like peptide-1 mimetic (exenatide) did not exert its physiological effects after oral administration, whereas it increased urinary sodium and potassium excretion following intramuscular injection.


Subject(s)
Intestinal Absorption/drug effects , Kidney/metabolism , Peptides/pharmacology , Vasotocin/pharmacology , Venoms/pharmacology , Water-Electrolyte Balance/drug effects , Water/metabolism , Administration, Oral , Animals , Exenatide , Female , Injections, Intramuscular , Potassium/urine , Rats , Rats, Wistar , Sodium/urine
8.
Ross Fiziol Zh Im I M Sechenova ; 101(7): 804-11, 2015 Jul.
Article in Russian | MEDLINE | ID: mdl-26591053

ABSTRACT

The aim of the study was a search of physiological approach to restoring osmotic homeostasis in rats with hypernatremia. Intraperitoneal administration of 1.8 ml/100 g BW 2.5% NaCl solution to Wistar rats induced hyperosmia (306 +/- 1 mOsm/kg H2O) and hypernatremia (150.3 +/- 0.3 mM in 60 min of experiment), increase in urinary sodium excretion (from 8 +/- 1 to 230 +/- 10 micromol/100 g BW for 2 h). Under these conditions enhancement of natriuresis up to 465 +/- 29 micromol/100 g BW and 667 +/- 24 micromol/100 g BW for 2 h was observed after injections of vasopressin analogue, deamino-vasotocin (dAVT, 0.05 microg/100 g BW), or loop diuretic, furosemide (1 mg/100 g BW), respectively. dAVT-induced natriuresis was accompanied by increase in solute-free water reabsorption; serum osmolality (301 +/- 1 mOsm/kg H2O) and sodium concentration (145.8 +/- 0.5 mM) were close to normal values by 60 min of experiment. Furosemide caused relatively greater excretion of water, than sodium; hypernatremia (150.2 +/- 0.4 mM) and hyperosmia (311 +/- 1 mOsm/kg H2O) persisted during 60 min of experiment. Thus, in rats with hypernatremia dAVT due to decrease in renal sodium reabsorption and increase in solute-free water reabsorption promotes recovery of serum osmolality and sodium concentration.


Subject(s)
Homeostasis , Hypernatremia/physiopathology , Osmotic Pressure , Animals , Diuretics/therapeutic use , Furosemide/therapeutic use , Hypernatremia/drug therapy , Male , Natriuresis , Rats , Rats, Wistar , Renal Reabsorption , Vasoconstrictor Agents/therapeutic use , Vasotocin/analogs & derivatives , Vasotocin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...